Fondazione IRCCS San Gerardo dei Tintori (Ospedale San Gerardo)

Monza 20900

4 studies enrolling now · 4 studies all time

What they study most

Homocystinuria, Relapsed/Refractory KMT2A-r Acute Leukemia, Relapsed/Refractory NPM1-m Acute Leukemia, Relapsed/Refractory NUP98-r Acute Leukemia, Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Studies at this site

• A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment — Recruiting now
• Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) — Recruiting now
• Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia — Recruiting now
• A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) — Enrolling by invitation